A UCLA Fielding School of Public Health professor and alumni has been named to the board of directors of a foundation that has supported nonprofit, community-based hospitals and health organizations across California for more than two decades.
Seven distinguished graduates of the UCLA Fielding School of Public Health have been named as members of the school’s “Hall of Fame” for 2025, recognizing their work since graduation as having a major impact on public health, both in Los Angeles and globally.
Dr. Ninez Ponce, professor and chair in the UCLA Fielding School's Department of Health Policy and Management, has been elected to serve on the board of directors of the California Health Care Foundation.
In 2024, the Los Angeles County program that provided free nighttime activities and programs in underserved areas continued its success, drawing more than 350,000 visits from people of all ages, including a 40% increase in adults ages 60 and older, according to a new study by the
Research co-authored by Dr. Carol Mangione, professor in the UCLA Fielding School’s Department of Health Policy and Management, found fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended screening age to 45 from 50.
In a testament to UCLA research that transforms lives across the globe, 39 faculty members - including four with UCLA Fielding - have been named among the world’s most influential scholars in the sciences and social sciences. The distinction reserved for only one out of every thousand researchers.
UCLA Fielding School of Public Health faculty brought the importance of academic research to an audience of more than 3,000, made up of new UCLA students and their families, at the annual Bruin Family Weekend events last week on the Westwood campus.
As breast cancer survival rates continue to climb — 4.3 million women in the U.S. are currently living with a history of the disease and in the next 10 years that number is expected to rise by another million — heart health has become an increasingly important part of survivorship care.
Certain breast cancer therapies, while lifesaving, can also place stress on the heart, raising important questions about who might benefit from closer monitoring.
But does every breast cancer survivor need to see a cardiologist?
While Artificial Intelligence (AI) can be a powerful tool that physicians can use to help diagnose their patients and has great potential to improve accuracy, efficiency and patient safety, it has its drawbacks. It may distract doctors, give them too much confidence in the answers it provides, and even lead them to lose confidence in their own diagnostic judgement.